News

 

 

Funding: New Awards

New Awards and Clinical Trials

Lionel Lewis, MD
Member, Molecular Therapeutics Research Program at Norris Cotton Cancer Center, and Professor of Medicine, Pharmacology & Toxicology

  • Genentech
    A Phase 1b, open-label pharmacokinetics and safety study of the hedgehog pathway inhibitor vismodegib in patients with advanced solid malignancies including hepatocellular carcinoma with varying degrees of renal or hepatic function

Deborah L. Ornstein, MD, MS
Member, Molecular Therapeutics Research Program at Norris Cotton Cancer Center, and Assistant Professor, Medicine and Pathology

  • PI/department funding
    MicroRNA expression in patients with myelodysplastic syndromes treated with hypomethylating drugs

J. Marc Pipas, MD
Member, Molecular Therapeutics Research Program at Norris Cotton Cancer Center, and Associate Professor, Medicine

  • DiagnoCure, Inc.
    Evaluation of guanylyl cyclase C and MMR status for colon cancer staging and prognosis
  • Incyte Corporation
    A randomized Phase 2 study of ruxolitinib efficacy and safety in combination with capecitabine for subjects with recurrent or treatment refractory metastatic pancreatic cancer (The RECAP trial)